Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-16T11:59:50.182Z Has data issue: false hasContentIssue false

Poly Lactic-Co-Glycolic Acid Carbon Nanofiber Composite for Enhancing Cardiomyocyte Function

Published online by Cambridge University Press:  25 March 2011

David A. Stout
Affiliation:
School of Engineering, Brown University, Providence, RI 02912, U.S.A.
Jennie Yoo
Affiliation:
Division of Biology and Medicine, Brown University, RI. 02912, U.S.A.
Thomas J. Webster
Affiliation:
School of Engineering, Brown University, Providence, RI 02912, U.S.A.Department of Orthopedics, Brown University, RI. 02912, U.S.A.
Get access

Abstract

The objective of the present in vitro research was to determine cardiomyocyte function on poly lactic-co-glycolic acid (50:50 (PLA:PGA); PLGA) with greater amounts of carbon nanofibers (CNFs) and variations in CNF size, for myocardial tissue engineering applications. The addition of CNFs would increase conductivity and strength of pure PLGA. For this reason, different PLGA: CNF ratios (100:0, 75:25, 50:50, 25:75, 0:100 wt.%) were created and conductivity and cytocompatibility properties with human cardiomyocytes were determined. Results showed that PLGA:CNF materials were conductive and that conductivity increased with greater amounts of PLGA added, from 0 S.m-1 for 100:0 wt.% (pure PLGA) to 5.5x10-3 S.m-1 for 0:100 wt.% (pure CNFs) material. Furthermore, results indicated that cardiomyocyte density increased with greater amounts of CNFs of 200nm in diameter in PLGA (up to 25:75 wt.% , PLGA:CNFs). This study, thus, provided an alternative conductive scaffold using nanotechnology which should be further explored for cardiovascular applications.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable